Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
JNJ-79635322 for Multiple Myeloma and AL Amyloidosis
Recruiting1 awardPhase 1
Irvine, California
This trial aims to determine the safe dosage and schedule for JNJ-79635322 in Part 1 and evaluate its safety and effectiveness in different disease subgroups in Part 2.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service